Metagenomi (MGX) announced that Eric Bjerkholt, CFO of Mirum Pharmaceuticals (MIRM), will join Metagenomi’s Board of Directors, serving on Metagenomi’s Audit and Compensation committees, effective January 27, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGX:
- Metagenomi price target raised to $14 from $7 at H.C. Wainwright
- Metagenomi presents updated preclinical NHP data at ASH meeting
- Metagenomi presents updated preclinical data in Hemophilia A at ASH
- Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks
- Class Action Lawsuit Against Metagenomi Inc. (NASDAQ:MGX)